An evaluation of FDG-PET as a predictor of metabolic response to chemotherapy in metastatic colorectal cancer patients (mCRC).
N. Van Damme
No relevant relationships to disclose
S. De Bruyne
No relevant relationships to disclose
J. Mertens
No relevant relationships to disclose
C. Van de Wiele
No relevant relationships to disclose
W. P. Ceelen
No relevant relationships to disclose
P. Smeets
No relevant relationships to disclose
L. Ferdinande
No relevant relationships to disclose
S. Laurent
No relevant relationships to disclose
K. Geboes
No relevant relationships to disclose
M. Peeters
Research Funding - Roche